| Theme | How Can We Realize the Philosophy of Chronic Kidney Disease-Mineral and Bone Disorder? | |
|---|---|---|
| Title | New drugs after the guideline publication -- how can we prescribe? | |
| Publish Date | 2010/01 | |
| Author | Takashi Akiba | Department of Blood Purificaion, Kidney Center, Tokyo Women's Medical University |
| [ Summary ] | New drugs which are approved near the time of guideline publication or after guideline publication seldom appear those guidelines. Taking cinacalcet as an example, we discussed how a new drug's clinical effects were anticipated in clinical medicine, how they were prescribed, and how the evidence was formulated after approval. We hope this discussion will help clinicians to understand how new drugs emerge in revised guidelines. | |